Animal model

The first antibiotic against tuberculosis that has been developed in Germany is now ready for clinical testing. BTZ043, as the newly developed drug substance is called, is also effective against

The Usutu virus endangers birds and has been circulating in Germany since 2010. However, estimating its impact on bird populations in the outbreak region has hardly been possible up to now. For the

Scientists have elucidated the Zika burden in a Brazilian metropolis. Their data indicate: the outbreak may be coming to an end and further outbreaks in the region seem unlikely. The study has also

DZIF researchers at the Helmholtz Centre for Infection Research (HZI) develop new agents and methods for the localisation and treatment of multi-resistant bacteria. Molecular probes utilise the iron

Severe malaria, caused by the Plasmodium falciparum parasite, causes dangerous circulatory disorders and neurological complications. If the affected person is not treated immediately, the disease will

The communities of microbes in the intestine of the mouse, the gut microbiota, have a significant impact on the research output. However, there is still insufficient information available about many

Researchers of the Paul Ehrlich Institute (PEI) together with groups at the DZIF have developed a vaccine against MERS, that is highly immunogenic and indicates protection of vaccinated mice in

In the EU project “EVIDENT”, scientists investigated around 180 patient samples from the Ebola epidemic in West Africa, to elucidate the origin of the epidemic in the individual countries and the

According to figures of the World Health Organization, some 8.7 million people contracted tuberculosis in 2012 and this disease is fatal for approximately 1.3 million people throughout the world each

A clinical phase I trial for a potential vaccine against the dreaded Ebola virus can now begin. The candidate vaccine has already successfully been tested in different animal models. The trial is